Systemic Amyloidosis Market - Forecast(2019 - 2024)

Report Code: HCR 0270 Report Format: PDF + Excel Database
Amyloids are the substance made up of abnormally formed protein in the bone marrow that gets saturated in different tissues or organs of the body. The condition is termed as amyloidosis. Amyloidosis is a clinical disorder caused by extracellular and/or intracellular deposition of insoluble abnormal amyloid fibrils that alter the normal function of tissues. Systemic amyloidosis (AL amyloidosis or just primary amyloidosis) is a medical condition which involves the mesenchymal tissue, the tongue, heart, gastrointestinal tract, and skin. Globally increasing awareness about systemic amyloidosis amongst people and increasing investment by companies to develop effective and new treatments is expected to drive the global demand for systematic amyloidosis market during the period of study.

This report identifies the global systemic amyloidosis market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to systemic amyloidosis market.
 


Geographically, North America dominated the systemic amyloidosis market due to because of high awareness, higher percentage of total income spent on healthcare compared to other economies and appropriate reimbursement circumstances and well developed healthcare infrastructure. North America was followed by Europe and Asia-Pacific as the second and third largest consumer of systemic amyloidosis. Asia Pacific is projected to have the fastest growth, owing to rapidly expanding healthcare infrastructure, increasing awareness especially in the major regional economies such as India and China in the region. 

This report segments systemic amyloidosis market on the basis of type and regional market as follows:

  • On the basis of type this report on systemic amyloidosis market is segmented as follows, covering major segments type as follows: Primary systemic amyloidosis (PSA), Amyloidosis associated with multiple myelomam, Secondary systemic amyloidosis and others
  • This report on systemic amyloidosis has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the systemic amyloidosis market. Some of the major companies’ profiles in detail are as follows:
  • Celgene Corporation
  • Prothena Corporation Plc
  • TheraPharm Deutschland GmbH
  • Johnson & Johnson
  • Onclave Therapeutics Limited Llc 
1. Systemic Amyloidosis Market – Overview
2. Executive Summary 
3. Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Systemic Amyloidosis Market– Forces
   4.1. Drivers
      4.1.1. Growing awareness about systemic amyloidosis amongst people
      4.1.2. Increasing investment by companies in R&D
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Systemic Amyloidosis Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life cycle Analysis
   5.5. Suppliers & Distributors
6. Systemic Amyloidosis Market, By Type
   6.1. Primary systemic amyloidosis (PSA)
   6.2. Amyloidosis associated with multiple myeloma
   6.3. Secondary systemic amyloidosis
   6.4. Others
7. Systemic Amyloidosis Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America 
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Systemic Amyloidosis – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Celgene Corporation
   9.2. Prothena Corporation Plc
   9.3. TheraPharm Deutschland GmbH
   9.4. Johnson & Johnson
   9.5. Amgen Inc.
   9.6. Onclave Therapeutics Limited Llc
* More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibiliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
List of Tables:

Table 1: Systemic Amyloidosis Market Overview 2019-2024
Table 2: Systemic Amyloidosis Market Leader Analysis 2018-2019 (US$)
Table 3: Systemic Amyloidosis Market Product Analysis 2018-2019 (US$)
Table 4: Systemic Amyloidosis Market End User Analysis 2018-2019 (US$)
Table 5: Systemic Amyloidosis Market Patent Analysis 2013-2018* (US$)
Table 6: Systemic Amyloidosis Market Financial Analysis 2018-2019 (US$)
Table 7: Systemic Amyloidosis Market Driver Analysis 2018-2019 (US$)
Table 8: Systemic Amyloidosis Market Challenges Analysis 2018-2019 (US$)
Table 9: Systemic Amyloidosis Market Constraint Analysis 2018-2019 (US$)
Table 10: Systemic Amyloidosis Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Systemic Amyloidosis Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Systemic Amyloidosis Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Systemic Amyloidosis Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Systemic Amyloidosis Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Systemic Amyloidosis Market Value Chain Analysis 2018-2019 (US$)
Table 16: Systemic Amyloidosis Market Pricing Analysis 2019-2024 (US$)
Table 17: Systemic Amyloidosis Market Opportunities Analysis 2019-2024 (US$)
Table 18: Systemic Amyloidosis Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Systemic Amyloidosis Market Supplier Analysis 2018-2019 (US$)
Table 20: Systemic Amyloidosis Market Distributor Analysis 2018-2019 (US$)
Table 21: Systemic Amyloidosis Market Trend Analysis 2018-2019 (US$)
Table 22: Systemic Amyloidosis Market Size 2018 (US$)
Table 23: Systemic Amyloidosis Market Forecast Analysis 2019-2024 (US$)
Table 24: Systemic Amyloidosis Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Systemic Amyloidosis Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 26: Systemic Amyloidosis Market By Type, Revenue & Volume, By Primary systemic amyloidosis (PSA), 2019-2024 ($)
Table 27: Systemic Amyloidosis Market By Type, Revenue & Volume, By Amyloidosis associated with multiple myeloma, 2019-2024 ($)
Table 28: Systemic Amyloidosis Market By Type, Revenue & Volume, By Secondary systemic amyloidosis, 2019-2024 ($)
Table 29: North America Systemic Amyloidosis Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 30: South america Systemic Amyloidosis Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 31: Europe Systemic Amyloidosis Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 32: APAC Systemic Amyloidosis Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 33: Middle East & Africa Systemic Amyloidosis Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 34: Russia Systemic Amyloidosis Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 35: Israel Systemic Amyloidosis Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 36: Top Companies 2018 (US$) Systemic Amyloidosis Market, Revenue & Volume
Table 37: Product Launch 2018-2019 Systemic Amyloidosis Market, Revenue & Volume
Table 38: Mergers & Acquistions 2018-2019 Systemic Amyloidosis Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Systemic Amyloidosis Market 2019-2024
Figure 2: Market Share Analysis for Systemic Amyloidosis Market 2018 (US$)
Figure 3: Product Comparison in Systemic Amyloidosis Market 2018-2019 (US$)
Figure 4: End User Profile for Systemic Amyloidosis Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Systemic Amyloidosis Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Systemic Amyloidosis Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Systemic Amyloidosis Market 2018-2019
Figure 8: Ecosystem Analysis in Systemic Amyloidosis Market 2018
Figure 9: Average Selling Price in Systemic Amyloidosis Market 2019-2024
Figure 10: Top Opportunites in Systemic Amyloidosis Market 2018-2019
Figure 11: Market Life Cycle Analysis in Systemic Amyloidosis Market
Figure 12: GlobalBy Type Systemic Amyloidosis Market Revenue, 2019-2024 ($)
Figure 13: Global Systemic Amyloidosis Market - By Geography
Figure 14: Global Systemic Amyloidosis Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 15: Global Systemic Amyloidosis Market CAGR, By Geography, 2019-2024 (%)
Figure 16: North America Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 17: US Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 30: Brazil Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 59: U.K Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 92: China Systemic Amyloidosis Market Value & Volume, 2019-2024
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($) Systemic Amyloidosis Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa Systemic Amyloidosis Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 121: Russia Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel Systemic Amyloidosis Market Value & Volume, 2019-2024 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Entropy Share, By Strategies, 2018-2019* (%) Systemic Amyloidosis Market
Figure 130: Developments, 2018-2019* Systemic Amyloidosis Market
Figure 131: Company 1 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 Systemic Amyloidosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 Systemic Amyloidosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 Systemic Amyloidosis Market Net Sales Share, By Geography, 2018 (%)